These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 39298816)

  • 1. Gut microbiota metabolite trimethylamine N-oxide promoted NAFLD progression by exacerbating intestinal barrier disruption and intrahepatic cellular imbalance.
    Nian F; Chen Y; Xia Q; Zhu C; Wu L; Lu X
    Int Immunopharmacol; 2024 Dec; 142(Pt B):113173. PubMed ID: 39298816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine.
    Shi C; Pei M; Wang Y; Chen Q; Cao P; Zhang L; Guo J; Deng W; Wang L; Li X; Gong Z
    Biochem Biophys Res Commun; 2022 Feb; 594():1-7. PubMed ID: 35065293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats.
    Zhao ZH; Xin FZ; Zhou D; Xue YQ; Liu XL; Yang RX; Pan Q; Fan JG
    World J Gastroenterol; 2019 May; 25(20):2450-2462. PubMed ID: 31171889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota metabolite TMAO promoted lipid deposition and fibrosis process via KRT17 in fatty liver cells in vitro.
    Nian F; Zhu C; Jin N; Xia Q; Wu L; Lu X
    Biochem Biophys Res Commun; 2023 Aug; 669():134-142. PubMed ID: 37271025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethylamine N-oxide induces non-alcoholic fatty liver disease by activating the PERK.
    Yang B; Tang G; Wang M; Ni Y; Tong J; Hu C; Zhou M; Jiao K; Li Z
    Toxicol Lett; 2024 Oct; 400():93-103. PubMed ID: 39153559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease.
    Tan X; Liu Y; Long J; Chen S; Liao G; Wu S; Li C; Wang L; Ling W; Zhu H
    Mol Nutr Food Res; 2019 Sep; 63(17):e1900257. PubMed ID: 31095863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis.
    Liu X; Sun R; Li Z; Xiao R; Lv P; Sun X; Olson MA; Gong Y
    Arch Biochem Biophys; 2021 Oct; 711():109019. PubMed ID: 34478730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between the gut microbiome, associated metabolites and the manifestation and progression of heart failure with preserved ejection fraction in ZSF1 rats.
    Guivala SJ; Bode KA; Okun JG; Kartal E; Schwedhelm E; Pohl LV; Werner S; Erbs S; Thiele H; Büttner P
    Cardiovasc Diabetol; 2024 Aug; 23(1):299. PubMed ID: 39143579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethylamine-N-oxide (TMAO) mediates the crosstalk between the gut microbiota and hepatic vascular niche to alleviate liver fibrosis in nonalcoholic steatohepatitis.
    Zhou D; Zhang J; Xiao C; Mo C; Ding BS
    Front Immunol; 2022; 13():964477. PubMed ID: 36072588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
    Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M
    J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Molecular and Mechanistic Insights Based on Gut-Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement.
    Ji Y; Yin Y; Sun L; Zhang W
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults.
    Chen YM; Liu Y; Zhou RF; Chen XL; Wang C; Tan XY; Wang LJ; Zheng RD; Zhang HW; Ling WH; Zhu HL
    Sci Rep; 2016 Jan; 6():19076. PubMed ID: 26743949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial metabolite trimethylamine-N-oxide induces intestinal carcinogenesis through inhibiting farnesoid X receptor signaling.
    Zhang W; Qin X; Zhang K; Ma J; Li M; Jin G; Liu X; Wang S; Wang B; Wu J; Liu T; Zhong W; Cao H
    Cell Oncol (Dordr); 2024 Aug; 47(4):1183-1199. PubMed ID: 38315283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD).
    Ji Y; Yin Y; Li Z; Zhang W
    Nutrients; 2019 Jul; 11(8):. PubMed ID: 31349604
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Huang Y; Cao J; Zhu M; Wang Z; Jin Z; Xiong Z
    Microbiol Spectr; 2024 Apr; 12(4):e0339323. PubMed ID: 38411057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
    Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
    Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia.
    Xue L; He J; Gao N; Lu X; Li M; Wu X; Liu Z; Jin Y; Liu J; Xu J; Geng Y
    Sci Rep; 2017 Mar; 7():45176. PubMed ID: 28349964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen inhalation ameliorates hepatic inflammation and modulates gut microbiota in rats with high-fat diet-induced non-alcoholic fatty liver disease.
    Xue J; Zhao M; Liu Y; Jia X; Zhang X; Gu Q; Xie Y; Qin S; Liu B
    Eur J Pharmacol; 2023 May; 947():175698. PubMed ID: 36997047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
    Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.